Serum S-100 β protein during coronary artery bypass graft surgery with or without cardiopulmonary bypass

Kuan Jen Wang, Hsiang Hua Wu, Shi-Yuan Fang, Yu Ren Yang, Chia-Chih Tseng

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background. Brain damage is a serious complication of cardiac anesthesia. The purpose of this study was to detect brain damage at different surgical stages during coronary artery bypass graft with or without cardiopulmonary bypass. Methods. We conducted a prospective, longitudinal study to evaluate serum S-100 β protein, an early marker of brain injury, in patients electively undergoing off-pump (n = 30) or traditional coronary artery bypass graft (n = 60). Blood was sampled immediately before anesthesia, before and after cardiopulmonary bypass, and on the day after surgery. Results. Serum S-100 β protein was lowest immediately before induction of anesthesia and significantly increased before and after cardiopulmonary bypass, then declined by the first postoperative day in both groups. Peak values were highest in the traditional group directly after coronary artery bypass graft. On the day after surgery, S-100 β protein levels were similar between groups, but were higher than baseline within each group. Significant increase in serum S-100 β protein was also observed even before cardiopulmonary bypass in cardiopulmonary bypass patients, or before manipulation of the heart and aorta in off-pump patients. These reflect the possibility that brain damage may occur before major manipulation (cardiopulmonary bypass or manipulating heart and aorta). Moreover, S-100 β levels did not return to normal on the day after the operation. Conclusions. This prospective study has shown that serum S-100 β protein was not only higher than baseline both after cardiopulmonary bypass and on the day after surgery in both groups of patients but it was also significantly increased before cardiopulmonary bypass or manipulation of the heart or aorta. These findings may have implications for anesthesiologic care during the total course of cardiac surgery.

Original languageEnglish
Pages (from-to)1371-1374
Number of pages4
JournalAnnals of Thoracic Surgery
Volume80
Issue number4
DOIs
Publication statusPublished - 2005 Oct 1

Fingerprint

S100 Proteins
Cardiopulmonary Bypass
Coronary Artery Bypass
Blood Proteins
Transplants
Ambulatory Surgical Procedures
Aorta
Anesthesia
Brain
Prospective Studies
Brain Injuries
Thoracic Surgery
Longitudinal Studies

All Science Journal Classification (ASJC) codes

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

@article{8f00f45e08dc49069dff4f91f6bd8239,
title = "Serum S-100 β protein during coronary artery bypass graft surgery with or without cardiopulmonary bypass",
abstract = "Background. Brain damage is a serious complication of cardiac anesthesia. The purpose of this study was to detect brain damage at different surgical stages during coronary artery bypass graft with or without cardiopulmonary bypass. Methods. We conducted a prospective, longitudinal study to evaluate serum S-100 β protein, an early marker of brain injury, in patients electively undergoing off-pump (n = 30) or traditional coronary artery bypass graft (n = 60). Blood was sampled immediately before anesthesia, before and after cardiopulmonary bypass, and on the day after surgery. Results. Serum S-100 β protein was lowest immediately before induction of anesthesia and significantly increased before and after cardiopulmonary bypass, then declined by the first postoperative day in both groups. Peak values were highest in the traditional group directly after coronary artery bypass graft. On the day after surgery, S-100 β protein levels were similar between groups, but were higher than baseline within each group. Significant increase in serum S-100 β protein was also observed even before cardiopulmonary bypass in cardiopulmonary bypass patients, or before manipulation of the heart and aorta in off-pump patients. These reflect the possibility that brain damage may occur before major manipulation (cardiopulmonary bypass or manipulating heart and aorta). Moreover, S-100 β levels did not return to normal on the day after the operation. Conclusions. This prospective study has shown that serum S-100 β protein was not only higher than baseline both after cardiopulmonary bypass and on the day after surgery in both groups of patients but it was also significantly increased before cardiopulmonary bypass or manipulation of the heart or aorta. These findings may have implications for anesthesiologic care during the total course of cardiac surgery.",
author = "Wang, {Kuan Jen} and Wu, {Hsiang Hua} and Shi-Yuan Fang and Yang, {Yu Ren} and Chia-Chih Tseng",
year = "2005",
month = "10",
day = "1",
doi = "10.1016/j.athoracsur.2005.04.011",
language = "English",
volume = "80",
pages = "1371--1374",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "4",

}

Serum S-100 β protein during coronary artery bypass graft surgery with or without cardiopulmonary bypass. / Wang, Kuan Jen; Wu, Hsiang Hua; Fang, Shi-Yuan; Yang, Yu Ren; Tseng, Chia-Chih.

In: Annals of Thoracic Surgery, Vol. 80, No. 4, 01.10.2005, p. 1371-1374.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Serum S-100 β protein during coronary artery bypass graft surgery with or without cardiopulmonary bypass

AU - Wang, Kuan Jen

AU - Wu, Hsiang Hua

AU - Fang, Shi-Yuan

AU - Yang, Yu Ren

AU - Tseng, Chia-Chih

PY - 2005/10/1

Y1 - 2005/10/1

N2 - Background. Brain damage is a serious complication of cardiac anesthesia. The purpose of this study was to detect brain damage at different surgical stages during coronary artery bypass graft with or without cardiopulmonary bypass. Methods. We conducted a prospective, longitudinal study to evaluate serum S-100 β protein, an early marker of brain injury, in patients electively undergoing off-pump (n = 30) or traditional coronary artery bypass graft (n = 60). Blood was sampled immediately before anesthesia, before and after cardiopulmonary bypass, and on the day after surgery. Results. Serum S-100 β protein was lowest immediately before induction of anesthesia and significantly increased before and after cardiopulmonary bypass, then declined by the first postoperative day in both groups. Peak values were highest in the traditional group directly after coronary artery bypass graft. On the day after surgery, S-100 β protein levels were similar between groups, but were higher than baseline within each group. Significant increase in serum S-100 β protein was also observed even before cardiopulmonary bypass in cardiopulmonary bypass patients, or before manipulation of the heart and aorta in off-pump patients. These reflect the possibility that brain damage may occur before major manipulation (cardiopulmonary bypass or manipulating heart and aorta). Moreover, S-100 β levels did not return to normal on the day after the operation. Conclusions. This prospective study has shown that serum S-100 β protein was not only higher than baseline both after cardiopulmonary bypass and on the day after surgery in both groups of patients but it was also significantly increased before cardiopulmonary bypass or manipulation of the heart or aorta. These findings may have implications for anesthesiologic care during the total course of cardiac surgery.

AB - Background. Brain damage is a serious complication of cardiac anesthesia. The purpose of this study was to detect brain damage at different surgical stages during coronary artery bypass graft with or without cardiopulmonary bypass. Methods. We conducted a prospective, longitudinal study to evaluate serum S-100 β protein, an early marker of brain injury, in patients electively undergoing off-pump (n = 30) or traditional coronary artery bypass graft (n = 60). Blood was sampled immediately before anesthesia, before and after cardiopulmonary bypass, and on the day after surgery. Results. Serum S-100 β protein was lowest immediately before induction of anesthesia and significantly increased before and after cardiopulmonary bypass, then declined by the first postoperative day in both groups. Peak values were highest in the traditional group directly after coronary artery bypass graft. On the day after surgery, S-100 β protein levels were similar between groups, but were higher than baseline within each group. Significant increase in serum S-100 β protein was also observed even before cardiopulmonary bypass in cardiopulmonary bypass patients, or before manipulation of the heart and aorta in off-pump patients. These reflect the possibility that brain damage may occur before major manipulation (cardiopulmonary bypass or manipulating heart and aorta). Moreover, S-100 β levels did not return to normal on the day after the operation. Conclusions. This prospective study has shown that serum S-100 β protein was not only higher than baseline both after cardiopulmonary bypass and on the day after surgery in both groups of patients but it was also significantly increased before cardiopulmonary bypass or manipulation of the heart or aorta. These findings may have implications for anesthesiologic care during the total course of cardiac surgery.

UR - http://www.scopus.com/inward/record.url?scp=25144464457&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25144464457&partnerID=8YFLogxK

U2 - 10.1016/j.athoracsur.2005.04.011

DO - 10.1016/j.athoracsur.2005.04.011

M3 - Article

VL - 80

SP - 1371

EP - 1374

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 4

ER -